ARCHIVES

NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

Centocor Withdraws Yondelis After FDA Calls for New Study

April 29, 2011

CCIRC Starts Preparing For Clinical Research Review; To Include Group Achievements, Problems

March 3, 1978

NCI Payline To Jump To 25th Percentile For A Portion Of Grants, Director Says

April 24, 2009

NCI Advisory Group, Other Cancer Meetings

May 29, 1987

Indoor Tanning Industry Funded Author Of NEJM Review On Vitamin D Deficiency.

April 18, 2008

Cancer Policy: Board Plans Paper On Tobacco Control

June 13, 1997